Replies to post #37783 on OncoSec Medical Inc (ONCSQ)

[Pazzo1212]

https://www.crunchbase.com/organization/mrl-venture-fund

http://www.m-ventures.com/portfolio

Click on these links and it shows you their portfolios.

Unless you're talking about another one

[lasers]

If it is the MRVF, then MRK most likely will partner with $ONCS with substantial upfront monies to fund the trial. MRK can risk failure but $ONCS cannot risk. A failure for MRK is "pocket change". Based on the Investigator trial there could be a 16 to 17% response success for the non-responders which would make it worthwhile for MRK and Keytruda.